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Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is rare among Japanese ethnicity although it
is known as one of the most common hereditary disorders of erythrocytes, causing intravascular hemolysis. It is
well-known that G6PD deficiency may cause hemolysis even in the neonatal period. However, most cases are
asymptomatic, and the frequency of severe anemia is low.
Findings: We describe a Japanese male neonatal case of G6PD deficiency presenting as severe, persistent indirect
hyperbilirubinemia on day 2 and hemolytic anemia. He was born to non-consanguineous Japanese parents without
any family history. We could not find any triggers that could have induced hemolysis during pregnancy.
Conclusions: This case encouraged us to investigate G6PD deficiency as a differential diagnosis of severe neonatal
jaundice and hemolytic anemia despite the low prevalence in Japan.
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Glucose-6-phosphate dehydrogenase (G6PD) deficiency is
said to be a rare disorder in Japan (Nakashima et al. 1977),
even though it is one of the most common genetic enzym-
atic disorders in the world (Steiner & Gallagher 2007).
The characteristic normal course of most G6PD-deficient
children includes no symptoms throughout their life, and
severe hyperbilirubinemia and kernicterus are seldom ob-
served in the newborn period (Cappellini & Fiorelli 2008).
In addition, acute severe hemolysis is thought to occur
with the presence of triggering factors, such as infection,
drugs, and fava beans (Cappellini & Fiorelli 2008; WHO
Working Group 1989; Kaplan et al. 1998).
We describe a neonatal case of G6PD deficiency that
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in any medium, provided the original work is pin the absence of ABO incompatibilities. The patient
was successfully treated and avoided complications.Case report
A male neonate was born at 38+5 weeks gestation to a
40-year-old gravida 2, para 2, blood group O Rh positive
mother, via spontaneous vaginal delivery. The pregnancy
was uncomplicated. Both his mother and father were
non-consanguineous Japanese parents without any past
medical history. His sibling (2-year-old girl) did not have
any jaundice. His birth weight was 3460 g (appropriate
for gestational age), and his Apgar score were 9 at 1 min
and 9 at 5 min. He was exclusively breastfed, although
the mother’s breast milk secretion was not sufficient.
On day 2, he looked icteric, and a blood test was
performed. His serum total bilirubin (STB) was 20.1 mg/dl
(the indication of phototherapy according to the criteria of
Kobe University, Japan: 12 mg/dl) (Department of
Pediatrics, Kobe University Graduate School of Medicine
1993), his serum direct bilirubin was 1.29 mg/dl (normalan Open Access article distributed under the terms of the Creative Commons
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due to severe jaundice and was admitted on the same day.
Physical examinations revealed a body weight of 3217 g
(7.0% weight loss). His vital signs were within normal
limits. His bulbar conjunctiva and skin were icteric, and
no hepatosplenomegaly was found. His blood type was
group B, Rh positive. A complete blood count (CBC) re-
vealed hemoglobin (Hb) of 12.6 g/dl and, a reticulocyte
count of 10.9%; a blood smear for red cell morphology
was within normal limits, without spherocytosis or red cell
fragments. Chemistry showed no abnormal findings, ex-
cept for STB (18.7 mg/dl). Direct and indirect Coombs’
tests were negative. Blood culture was negative. Urinaly-
sis did not show any occult blood, urobilinogen or bac-
teria. Chest and abdominal radiographs were normal.
Head ultrasonography (US) showed no intracranial
hemorrhage and abdominal US did not reveal any ad-
renal hemorrhage.
An exchange transfusion was reserved because of
the patient’s STB (the criteria for indication was an
STB>20 mg/dl, according to Kobe University), and photo-
therapy was initiated. Table 1 shows the course of the
blood test results and management. A total of 15 ml/kg of
red blood cells (RBCs) was transfused on 2 consecutive
days (days 16 and days 17). After the RBCs transfusion, a
CBC showed 14.3 g/dl of Hb. On day 16, an erythrocyte
osmotic fragility test, CD55 and CD59 were within nor-
mal limits. He was referred to Tokyo Women’s Medical
University to further investigate any erythrocyte disor-
ders. His glucose-6-phosphate dehydrogenase activity was
3.06 IU/gHb (his father and mother’s activity was not
available), while the normal level is 11.0 IU/gHb. The pa-
tient was diagnosed as having a G6PD deficiency. Two
weeks after birth, his jaundice and anemia became stable
without any treatment and he was discharged on day 21
with an STB value of 14.7 mg/dl, Hb of 12.9 g/dl and a re-
ticulocyte count of 2.0%.Table 1 Serum bilirubin, hematological values and other man
DOL 2 5 9 13
Blood Test
Hb (g/dl) 12.6 12.0 9.4 8.6
Hct (%) 37.1 35.6 28.1 25.5
Ret (%) 10.9 5.4 2.5 4.1
STB (mg/dl) 18.7 18.5 14.4 19.2
Management
Phototherapy† + + - +
Transfusion
Other tests‡
Abbreviations: DOL Day of life, Hb Hemoglobin, Hct Hematocrit, Ret Reticulocyte, ST
† treatment with phototherapy is indicated with a +.
‡ an osmotic fragility test was performed on DOL 16; an erythrocyte enzyme test wDiscussion
We treated a Japanese male with severe and refractory
jaundice and progressive, early onset normocytic anemia
born to non-consanguineous parents. The signs of
hemolysis were obscure at the onset of jaundice. Rh,
ABO compatibilities and spherocytosis were not ob-
served. Because the erythrocyte enzyme test is not easily
accessible in Japan, the infant was referred to a specific
institute, and was eventually diagnosed as having a
G6PD deficiency on day 75. The instructive aspects of
the present report are as follows. First, although G6PD
deficiency is uncommon in Japan, the patient was born
to Japanese parents. Second, the case presented as severe
jaundice and hemolytic anemia, although most cases are
asymptomatic, particularly in the neonatal period. Third,
he apparently did not have any triggers for an acute epi-
sode of hemolysis.
The prevalence of G6PD deficiency is estimated at ap-
proximately 0.1% in Japan (Nakashima et al. 1977). In
most hemolytic cases, it was inferred that the mothers
were of non-Japanese ethnicity because gene variants
found in Japan were not associated with severe hemo-
lytic anemia (Nakashima et al. 1977). This also might be
attributed to the fact that the incidence of gene mutation
was quite different from southern Chinese in the
Taiwan-Hakka population and Philippines (5.5% and
6.0% each) (Nakashima et al. 1977). In fact, case reports
of G6PD deficiency with severe hemolytic anemia pub-
lished in Japan often describe the family history of for-
eign mothers (Shimomura et al. 2002; Akazawa et al.
2011). Therefore this case was also characteristic in the
point that both the father and mother are Japanese.
Most G6PD-deficient individuals are entirely asymp-
tomatic (Mehta 1994). The most common clinical mani-
festation in the neonatal period is neonatal jaundice, and
acute hemolytic anemia is usually rare; this is because
neonatal jaundice due to G6PD deficiency is not due toagements during hospitalization
16 17 31 75 94 149
7.0 14.3 10.8 8.4 7.9 9.1
20.6 40.8 31.4 24.1 23.7 28.1
4.0 2.2 0.5 4.6 7.5 8.6
14.7 14.6 13.9 4.2 2.0 2.0
- - - - - -
* *
+ +
B Serum total bilirubin.
as performed on DOL 75.
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ondary to reduced hepatic conjugation and bilirubin ex-
cretion (Cappellini & Fiorelli 2008; Beutler 1994; Kaplan
& Hammerman 2002). Our case presented neonatal
jaundice in advance of the hemolytic anemia; however,
the increased reticulocyte count on day 2 suggests that
both hyperbilirubinemia and hemolysis may occur sim-
ultaneously. Kawaguchi et al. also reported a suspected
antenatal hemolysis case in Japan (Kawaguchi et al.
1997). In this case, an extremely high reticulocyte level
(344‰) was presented, and intrauterine hemorrhage was
strongly suspected. They attributed the early onset
hemolysis to oxidative stress as a result of maternal his-
tory of the common cold or drug use.
This illness generally manifests as acute hemolysis in
childhood, which usually arises when red blood cells
undergo oxidative stress triggered by infection or the in-
gestion of fava beans. Despite conducting a thorough
and precise interview, we could not identify any history
of drug or food intake during the pregnancy. There have
been a few G6PD deficiency cases presenting acute
hemolysis in the absence of any trigger that have also
been reported in the literature (Dhillon et al. 2003; Shah
& Yeo 2007). Our case supports the theory that massive
hemolysis may occur in neonates with G6PD deficiency
even in the absence of obvious triggering factors.
The abnormal genetic mutations of this disease are clas-
sified into 3 categories. Class V/IV is clinically asymptom-
atic, and class III/II (the border between III and II is not
obvious) is basically asymptomatic; both are without the
risk of hemolytic anemia and neonatal jaundice. Class I
presents (severe) neonatal jaundice and acute exacerbation
of hemolytic anemia (WHO Working Group 1989). The
limitation of our report is that this case should be classi-
fied as class I because the patient showed both acute and
chronic hemolytic episodes. However, no genetic testing
has been performed. Differences in the clinical course due
to genetic transmutation may be present in this disorder.
Therefore, genetic testing is one of important part of the
management of G6PD patients.
The Japanese male neonate with G6PD deficiency in this
report simultaneously presented with severe jaundice and
acute hemolysis. Given the lack of family history, triggers,
definite laboratory data, and rare disease status among pa-
tients with Japanese ethnicity, we recommend further in-
vestigation for G6PD deficiency in cases of neonatal
hemolytic anemia complicated with jaundice.
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